AzTrials
AzTrials

HivNCT06389565

Change My Story Task Shifted Mental Health Intervention

A study testing Problem Solving Therapy and Change My Story in people with Hiv and Depression, run by Massachusetts General Hospital at 1 site in Nigeria.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Psychological distress and depression are common among young people living with HIV (Y-PLWH) and negatively impact medication adherence and disease control. In low- and middle-income countries, this problem is compounded by the lack of trained mental health professionals on the provider side and the requirement of… Read more about this study

Who is it for?
Ages 16 to 29 years
Conditions the study is for
Hiv, Depression, Psychological Distress
What is being tested?
Problem Solving Therapy and Change My Story
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteNigeria
Study dates
9 Jan 2026to 30 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 29 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • HIV-positive
  • age 16-29 years
  • self-reported proficiency in reading and understanding English.
  • PHQ9 score of 9-17 and impairment in functioning (consistent with clinical depression)

Who cannot join

  • pregnant or nursing
  • in care and on ART for <6 months
  • history of- or positive assessment for- bipolar or psychotic disorder.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Aima a Ahonkhai, MD contact

617-726-3906

AAHONKHAI@mgh.harvard.edu

Nigeria1 site, 1 recruiting
  • University of Ibadan

    Ibadan, Oyo State

    Bibilola Oladeji, MBBS, 234 02-2914-130, bibideji@yahoo.com

    Recruiting

Other trials in Nigeria

About this study

Official title: Change My Story: Pilot Randomized Clinical Trial of Change My Story Among Young Persons Living With HIV and Depression

Psychological distress and depression are common among young people living with HIV (Y-PLWH) and negatively impact medication adherence and disease control. In low- and middle-income countries, this problem is compounded by the lack of trained mental health professionals on the provider side and the requirement of frequent clinic-based visits imposing greater cost, inconvenience, and stigma for patients. Change My Story, is a theory-grounded, interactive narrative game designed to address the key drivers of depression and psychological distress among Y-PLWH in Nigeria. This pilot hybrid implementation-effectiveness randomized controlled trial (RCT) will compare Change My Story combined with PST to PST alone among 80 Y-PLWH with depression or psychological distress.

Read the detailed description

Young people living with HIV (Y-PLWH) have poor adherence to antiretroviral therapy and engagement in HIV care, making HIV the leading cause of death for African adolescents. Depression and psychological distress are much more common among Y-PLWH than in the general population, and are associated with significantly worse adherence to care and treatment when compared to Y-PLWH without these co-morbid conditions. Thus, untreated depression and severe psychological distress are important contributors to poor HIV outcomes in this population. Nigeria is home to the 4th largest HIV population globally and 10% of Y-PLWH, but mental health screening is not routinely conducted in this setting, and less than 10% of those diagnosed have access to evidence-based care. Despite this treatment gap, few interventions have targeted the mental health needs of Y-PLWH in Africa. The World Health Organization recommends that caregivers of Y-PLWH adopt youth-friendly strategies and incorporate psychosocial services to meet their needs, and that task shifting to non-specialized health workers be used to overcome the dearth of trained professionals in low and middle-income countries. Task-shifted problem Solving Therapy (PST) has been effectively used to treat both depression and psychological distress using a task-shifted approach. However, PST is an intensive strategy (typically 6-15 weekly sessions) often delivered in-person and poor completion rates are associated with less effectiveness. Mobile health technologies may be uniquely suited to surmount some of the obstacles for effective A theory-grounded game, Change My Story, has been developed which allows players navigate difficult experiences based on drivers of psychological distress and interact with a virtual environment this research aims to 1) conduct a hybrid implementation-effectiveness pilot RCT for 80 Y-PLWH with depression or psychological distress, and compare feasibility, acceptability, engagement, satisfaction and preliminary effectiveness among individuals receiving PST alone or PST with Change My Story, and 2) use the Consolidated Framework for Implementation Research (CFIR) to assess factors influencing engagement, acceptability, and satisfaction along with facilitators and barriers to implementation delivery.

Being tested
Problem Solving Therapy, Change My Story
Medical subject headings
Acquired Immunodeficiency Syndrome, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Problem Solving TherapyBehavioural

    Problem solving therapy (PST) is a cognitive-behavioral therapy (CBT)-based intervention that uses seven basic steps to teach problem solving orientation and skills to equip individuals to manage the impact of stressful life events on their mental health.

  • Change My StoryOther

    Change My Story is a narrative game with a choose-your-own-adventure format in which players navigate emotionally difficult experiences along with the character(s) and interact with the virtual environment to choose a narrative path toward the story's conclusion. It will used to address important obstacles in the mental health treatment gap for Y-PLWH.

Study groups in NCT06389565
Study groupRoleWhat they receive
PST aloneActive comparatorPatients randomized to PST alone will receive PST delivered using a stepped-care approach. Subsequent care will be determined based on participant PHQ-9 score at the week 6 evaluation. All participants who do not achieve remission (PHQ-9 <12) after completion of the additional six-week therapy sessions, will be required to have a referral to either the general MD or psychiatrist at the clinic to determine need for pharmacologic treatment or additional intervention based on local clinical practice guidelines. During each PST session, the HIV counselor will ask the participant structured questions to identify those at risk of suicide, or with adverse reactions to prescribed antidepressants. Participants who indicate suicidality (plan/attempt) during PST sessions, or ongoing refractory disease (at reassessment points) will require immediate consultation by the psychiatry clinic.
Receives: Behavioral: Problem Solving Therapy
PST with Change My StoryExperimentalIn addition to all activities described in the PST alone arm, at enrollment, participants in the arm with Change My Story, will download the game onto their phones, receive instructions about the game and receive recommendations on how to play the game (at least one narrative for one of the three characters) each week within 48 hours of the PST session. Participants will be encouraged to set a weekly reminder alarm for their game play session. Participants will have an opportunity to explore the game at will according to these loose parameters prior to the first PST session.
Receives: Behavioral: Problem Solving Therapy; Other: Change My Story

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Engagement

    The percentage of recommended problem solving therapy sessions attended.

    Measured: 3 months

  2. Patient Satisfaction with Interventionn

    Based on an adapted version of the client satisfaction questionnaire (CSQ-8). Total scores range from 8 to 32, with the higher number indicating greater satisfaction.

    Measured: 3 months

  3. Feasibility 1

    Weiner's feasibility of an intervention (FIM). Scales can be created for each measure by averaging responses. Scale values range from 1 to 5.

    Measured: 3 months

  4. Feasibility 2

    Proportion of consented patients enrolled

    Measured: 3 months

  5. Feasibility 3

    Proportion of game play sessions interrupted by technical problems

    Measured: 3 months

  6. Feasibility 4

    Proportion of users requiring mobile phone (at baseline) or requiring a replacement phone (due to loss or theft)

    Measured: 3 months

  7. Feasibility 5

    Proportion of users requiring mobile phone

    Measured: Baseline

  8. Feasibility 6

    Proportion of users requiring mobile phone replacement due to loss or theft

    Measured: 3 months

  9. Feasibility 7

    Proportion in need for additional data bundles

    Measured: 3 months

  10. Acceptability 1

    Weiner's acceptability of an intervention. Scales can be created for each measure by averaging responses. Scale values range from 1 to 5.

    Measured: Once

  11. Acceptability 2

    Number of minutes of total game play per month

    Measured: up to 3 months

  12. Acceptability 3

    Number of days of total game play per month

    Measured: up to 3 months

  13. Acceptability 4

    Percentage of recommended game play minutes completed

    Measured: 3 months

  14. Acceptability 5

    Proportion of narratives completed assessed from aggregated game play metrics

    Measured: 3 months

Secondary outcomes (4)
  1. Remission of depression.

    Patient health questionnaire-9. For this research, a PHQ-9 score < 6 will be considered in remission.

    Measured: 3 and 6 months

  2. Remission of psychological distress.

    Self reporting questionnaire-20. For this research, a SRQ-20 < 5 will be considered in remission.

    Measured: 3 and 6 months

  3. ART adherence

    Based on % pharmacy refill

    Measured: 3 and 6 months

  4. Viral suppression

    VL < 200 copies/mL

    Measured: 3 to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2024
  2. Study start9 Jan 2026
  3. Primary completion30 Aug 2026 (estimated)
  4. Study completion30 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06389565
Sponsor's protocol ID
2024p000857
Status last verified
Jul 2026
First submitted
9 Apr 2024
Last updated
6 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Eliazer C, Omotosho T, Kuti KM, Pierce LJ, Gray D, Audet CM, Awolude O, Gureje O, Oladeji B, Ahonkhai AA. A Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2025 Dec 3;14:e74199. doi: 10.2196/74199.

    PubMed 41337738

Questions about this trial

What is this clinical trial studying?

A study testing Problem Solving Therapy and Change My Story in people with Hiv and Depression, run by Massachusetts General Hospital at 1 site in Nigeria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aima a Ahonkhai, MD (617-726-3906, AAHONKHAI@mgh.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Engagement (time frame: 3 months). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06389565, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in